These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38023534)

  • 1. Turning the promise of multipurpose prevention technologies into a market reality: a commentary.
    Dam A; Schueller J; Peine KJ; Mason J; Dorward E; Vij A
    Front Reprod Health; 2023; 5():1181043. PubMed ID: 38023534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Promise of the Dual Prevention Pill: A Framework for Development and Introduction.
    Friedland BA; Mathur S; Haddad LB
    Front Reprod Health; 2021 Jun; 3():. PubMed ID: 34318291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equipping providers to offer novel MPTs: Developing counseling messages for the Dual Prevention Pill in clinical studies and beyond.
    Segal K; Harris DM; Carmone A; Haddad LB; Hadigal S; Hatzold K; Jones C; Lathrop E; Mason J; Mikulich M
    Front Reprod Health; 2023; 5():1155948. PubMed ID: 37284490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.
    Milali MP; Resar D; Kaftan D; Campbell J; Olowu A; Edwards D; Platais I; Kim HY; Jenkins S; Bershteyn A
    Front Reprod Health; 2023; 5():1144217. PubMed ID: 37266447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How might we motivate uptake of the Dual Prevention Pill? Findings from human-centered design research with potential end users, male partners, and healthcare providers.
    Nyagah W; Segal K; Feltham J; Ash A; Major J; Masani M
    Front Reprod Health; 2023; 5():1254953. PubMed ID: 38023531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
    Brady M; Manning J
    Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perception of couples' on multipurpose prevention technology attribute choice: the case of MTN 045.
    Dandadzi A; Young AM; Musara P; Shapley-Quinn MK; Kemigisha D; Mutero P; Mgodi NM; Etima J; Minnis AA
    BMC Public Health; 2024 Jul; 24(1):1876. PubMed ID: 39004714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipurpose prevention technologies: products in development.
    Friend DR; Clark JT; Kiser PF; Clark MR
    Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.
    Bershteyn A; Resar D; Kim HY; Platais I; Mullick S
    Front Reprod Health; 2023; 5():1169110. PubMed ID: 37325241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa.
    Minnis AM; Krogstad E; Shapley-Quinn MK; Agot K; Ahmed K; Danielle Wagner L; van der Straten A;
    Sex Reprod Health Matters; 2021 Dec; 29(1):1927477. PubMed ID: 34224341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
    Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
    Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
    Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
    Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
    Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key programmatic and policy considerations for introducing multipurpose prevention (MPT) methods: reflections from healthcare providers and key stakeholders in South Africa.
    Kutywayo A; Mataboge P; Mthimkhulu N; Martin CE; Muhwava LS; Mazibuko M; Makalela N; Kwatsha K; Butler V; Mullick S
    Front Reprod Health; 2024; 6():1249750. PubMed ID: 38444890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
    Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
    Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Multipurpose prevention technologies for HIV, STIs and pregnancies.
    Friedland BA; Thurman AR; Nuwagaba-Biribonwoha H; Malcolm RK
    Front Reprod Health; 2024; 6():1384153. PubMed ID: 38476596
    [No Abstract]   [Full Text] [Related]  

  • 17. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
    Gachigua SG; Karuga R; Ngunjiri A; Jarrahian C; Coffey PS; Kilbourne-Brook M; Otiso L
    Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Securing accelerated access to long-acting injectable cabotegravir for HIV prevention in low- and middle-income countries.
    Jenkins SY; Resar D; Panos Z; Staple A; Watkins M; Ripin D; Amole C
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26101. PubMed ID: 37439082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention method preferences and factors influencing hypothetical choice among women in South Africa: a survey exploring opportunities for a multipurpose prevention technology implant.
    Martin CE; Kutywayo A; Mataboge P; Chidumwa G; Mthimkhulu N; Bothma R; Mullick S
    Front Reprod Health; 2024; 6():1368889. PubMed ID: 38983594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
    Roche SD; Barnabee G; Omollo V; Mogaka F; Odoyo J; Bukusi EA; Morton JF; Johnson R; Celum C; Baeten JM; O'Malley G
    BMC Health Serv Res; 2022 Mar; 22(1):422. PubMed ID: 35354456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.